XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative effect of adoption of ASU 2020-06
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative effect of adoption of ASU 2020-06
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative effect of adoption of ASU 2020-06
Balances (in shares) at Dec. 31, 2021     206,739,874          
Balances at Dec. 31, 2021 $ 107,348 $ (18,196) $ 0 $ 2,022,701 $ (36,868) $ 203 $ (1,915,556) $ 18,672
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation expense 7,996     7,996        
Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)     354,089          
Shares issued upon vesting of restricted stock units 1     1        
Shares issued for accrued compensation (in shares)     772,071          
Shares issued for accrued compensation 1,698     1,698        
Shares issued as payment for services (in shares)     283,987          
Shares issued as payment for services 576     576        
Net income 50,493           50,493  
Other comprehensive loss (7,384)         (7,384)    
Balances (in shares) at Sep. 30, 2022     208,150,021          
Balances at Sep. 30, 2022 142,532   $ 0 1,996,104   (7,181) (1,846,391)  
Balances (in shares) at Jun. 30, 2022     208,150,021          
Balances at Jun. 30, 2022 55,653   $ 0 1,993,979   (4,556) (1,933,770)  
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation expense 2,125     2,125        
Net income 87,379           87,379  
Other comprehensive loss (2,625)         (2,625)    
Balances (in shares) at Sep. 30, 2022     208,150,021          
Balances at Sep. 30, 2022 $ 142,532   $ 0 1,996,104   (7,181) (1,846,391)  
Balances (in shares) at Dec. 31, 2022 208,150,021   208,150,021          
Balances at Dec. 31, 2022 $ 126,259   $ 0 1,998,314   (3,488) (1,868,567)  
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation expense 7,626     7,626        
Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)     751,233          
Shares issued upon vesting of restricted stock units 0     0        
Shares issued for accrued compensation (in shares)     3,068,825          
Shares issued for accrued compensation 3,361     3,361        
Shares issued as payment for services (in shares)     465,808          
Shares issued as payment for services 545     545        
Shares issued in public offering, net of issuance costs (in shares)     43,962,640          
Shares issued in public offering, net of issuance costs 72,808     72,808        
Net income (62,848)           (62,848)  
Other comprehensive loss $ (73)         (73)    
Balances (in shares) at Sep. 30, 2023 256,398,527   256,398,527          
Balances at Sep. 30, 2023 $ 147,678   $ 0 2,082,654   (3,561) (1,931,415)  
Balances (in shares) at Jun. 30, 2023     255,482,753          
Balances at Jun. 30, 2023 166,210   $ 0 2,080,348   (2,518) (1,911,620)  
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation expense 2,306     2,306        
Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)     53,418          
Shares issued upon vesting of restricted stock units 0     0        
Shares issued for accrued compensation (in shares)     862,356          
Shares issued for accrued compensation 0     0        
Net income (19,795)           (19,795)  
Other comprehensive loss $ (1,043)         (1,043)    
Balances (in shares) at Sep. 30, 2023 256,398,527   256,398,527          
Balances at Sep. 30, 2023 $ 147,678   $ 0 $ 2,082,654   $ (3,561) $ (1,931,415)